We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.

Geneos Wealth Management Inc. decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% ...

Brighton Jones LLC purchased a new position in Edwards Lifesciences Co. (NYSE:EW – Free Report) in the fourth quarter, ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Let's talk about the popular Edwards Lifesciences Corporation ( NYSE:EW ). The company's shares saw significant share... Edwards Lifesciences (NYSE:EW) has had a rough week with its share price ...

Stifel upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said the upgrade is predicated on “now more credible TAVR growth re-acceleration ...

Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, or transcatheter aortic valve replacement ...